Large-scale testing (Phase 3)Study completedNCT00086593
What this trial is testing
Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia
Who this might be right for
Schizophrenia
GlaxoSmithKline 209
Showing 20 of 165 results